Ogino et al. respond to "the 21st century epidemiologist"

American Journal of Epidemiology

Volumn 176, Issue 8, 2012, Pages 672-674

  Ogino, Shuji ^a,b,c,d   Beck, Andrew H ^a,e   King, Emily E ^b   Sherman, Mark E ^f   Milner, Danny A ^b,c   Giovannucci, Edward ^a,b,c  

^a DANA FARBER HARVARD CANCER CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLORECTAL CANCER; CONCEPTUAL FRAMEWORK; HUMAN; LONG INTERSPERSED REPEAT; MEDICAL EDUCATION; MEDICAL RESEARCH; MICROSATELLITE INSTABILITY; MOLECULAR EPIDEMIOLOGY; MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; MORBIDITY; MORTALITY; NOTE; PATIENT CODING; SPECIALIZATION;

EPIDEMIOLOGY; HUMANS; INTERDISCIPLINARY COMMUNICATION; MODELS, EDUCATIONAL; PATHOLOGY; PUBLIC HEALTH;

EID: 84867725133     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws229     Document Type: Note

References (29)

1. Kuller LH. Invited commentary: the twenty-first century epidemiologist-a need for different training? Am J Epidemiol. 2012;176(8):668-671.
2. Ogino S, King EE, Beck AH, et al. Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. Am J Epidemiol. 2012;176(8):659-667.
3. Ogino S, Giovannucci E. Lifestyle factors and colorectal cancer microsatellite instability: molecular pathological epidemiology science, based on unique tumor principle [published online ahead of print May 16, 2012]. Int J Epidemiol. (doi:10.1093/ije/dys076).
4. Ogino S, Stampfer M. Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology. J Natl Cancer Inst. 2010;102(6):365-367.
5. Ogino S, Galon J, Fuchs CS, et al. Cancer immunology-analysis of host and tumor factors for personalized medicine. Nat Rev Clin Oncol. 2011;8(12):711-719.
6. Ogino S, Chan AT, Fuchs CS, et al. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut. 2011; 60(3):397-411.
7. Curtin K, Slattery ML, Samowitz WS. CpG island methylation in colorectal cancer: past, present and future. Pathol Res Int. 2011;2011:902674. (doi:10.4061/2011/902674).
8. Hughes LA, Khalid-de Bakker CA, Smits KM, et al. The CpG island methylator phenotype in colorectal cancer: progress and problems. Biochim Biophys Acta. 2012; 1825(1):77-85.
9. Hughes LA, Simons CC, van den Brandt PA, et al. Body size, physical activity and risk of colorectal cancer with or without the CpG island methylator phenotype (CIMP). PLoS ONE. 2011;6(4):e18571. (doi:10.1371/journal.pone. 0018571).
10. Boyle T, Fritschi L, Heyworth J, et al. Long-term sedentary work and the risk of subsite-specific colorectal cancer. Am J Epidemiol. 2011;173(10):1183- 1191.
11. Kelley RK, Wang G, Venook AP. Biomarker use in colorectal cancer therapy. J Natl Compr Canc Netw. 2011; 9(11):1293-1302.
12. Chen D, Song S, Lu J, et al. Functional variants of-1318T > G and-673C > T in c-Jun promoter region associated with increased colorectal cancer risk by elevating promoter activity. Carcinogenesis. 2011;32(7):1043-1049.
13. Campbell PT, Newton CC, Dehal AN, et al. Impact of body mass index on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol. 2012;30(1):42-52.
14. Boyle T, Heyworth J, Bull F, et al. Timing and intensity of recreational physical activity and the risk of subsite-specific colorectal cancer. Cancer Causes Control. 2011;22(12): 1647-1658.
15. Gehoff A, Basten O, Sprenger T, et al. Optimal lymph node harvest in rectal cancer (UICC stages II and III) after preoperative 5-FU-based radiochemotherapy. Acetone compression is a new and highly efficient method. Am J Surg Pathol. 2012;36(2):202-213.
16. Iwagami S, Baba Y, Watanabe M, et al. Pyrosequencing assay to measure LINE-1 methylation level in esophageal squamous cell carcinoma. Ann Surg Oncol. 2012;19(8): 2726-2732.
17. Esteban S, Moya P, Fernandez-Suarez A, et al. Diagnostic and prognostic utility of methylation and protein expression patterns of myopodin in colon cancer. Tumour Biol. 2012; 33(2):337-346.
18. Hughes LA, Williamson EJ, van Engeland M, et al. Body size and risk for colorectal cancers showing BRAF mutation or microsatellite instability: a pooled analysis [published online ahead of print April 24, 2012]. Int J Epidemiol. (doi:10.1093/ije/dys055).
19. Limburg PJ, Limsui D, Vierkant RA, et al. Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older women. Cancer Epidemiol Biomarkers Prev. 2012;21(4):681-684.
20. Limsui D, Vierkant RA, Tillmans LS, et al. Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women [published online ahead of print October 24, 2011]. Gut. (doi:10.1136/gutjnl- 2011-300719).
21. Ogino S, Goel A. Molecular classification and correlates in colorectal cancer. J Mol Diagn. 2008;10(1):13-27.
22. Lao VV, Grady WM. Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol. 2011;8(12):686-700.
23. Campbell PT, Jacobs ET, Ulrich CM, et al. Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst. 2010;102(6):391-400.
24. Slattery ML, Curtin K, Anderson K, et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst. 2000;92(22): 1831-1836.
25. Satia JA, Keku T, Galanko JA, et al. Diet, lifestyle, and genomic instability in the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev. 2005;14(2): 429-436.
26. Kuchiba A, Morikawa T, Yamauchi M, et al. Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the Nurses' Health Study. J Natl Cancer Inst. 2012;104(5):415-420.
27. Schernhammer ES, Giovannucci E, Kawasaki T, et al. Dietary folate, alcohol, and B vitamins in relation to LINE-1 hypomethylation in colon cancer. Gut. 2010; 59(6):794-799.
28. Chan AT, Ogino S, Fuchs CS. Aspirin use and survival after diagnosis of colorectal cancer. JAMA. 2009;302(6): 649-658.
29. Morikawa T, Kuchiba A, Yamauchi M, et al. Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer. JAMA. 2011;305(16):1685-1694.